Surgery Partners Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -40.2% | -35.0% | +103.4% | -21.3% | +70.9% | -94.6% | +1,255.0% | +2.8% | +23.7% | -88.7% | +406.8% | – | |
| – | +7.6% | +8.4% | +3.3% | +44.3% | -32.5% | +7.1% | +11.0% | -2.0% | +51.6% | -35.7% | -200.0% | – | |
| – | +2.3% | +8.9% | +208.2% | -53.0% | -12.7% | +22.6% | -10.5% | -61.8% | -184.6% | – | -200.0% | – | |
| – | -401.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.8% | +6.1% | +28.1% | -24.9% | +10.4% | +1.8% | +3.1% | -15.4% | -35.4% | +25.0% | +36.3% | – | |
| – | +127.0% | +43.0% | +193.7% | -79.7% | +125.2% | -31.6% | – | -2,300.0% | +172.9% | -89.4% | +47.8% | – | |
| – | – | – | – | – | +185.6% | -1.2% | -112.2% | +187.8% | – | -98.6% | +2,287.5% | – | |
| – | +118.6% | – | +498.1% | -103.9% | – | -37.1% | -307.3% | +34.3% | – | -194.4% | -90.9% | – | |
| – | -168.4% | – | – | -70.7% | +474.7% | -184.3% | – | -324.5% | – | -257.8% | – | – | |
| – | -50.1% | -54.0% | +183.8% | -19.5% | +98.0% | -118.7% | – | +10.2% | +42.0% | -104.7% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.